B43.9
Chromomycosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Chromomycosis, also known as chromoblastomycosis, is a chronic fungal infection of the skin and subcutaneous tissues. It is primarily caused by the inhalation or inoculation of specific types of fungi present in soil and plant material. The infection typically develops slowly, leading to the formation of dark, wart-like lesions that can become ulcerated or scarred over time. While it is considered a rare disease, chromomycosis is more common in tropical and subtropical regions and affects individuals who have frequent contact with soil or organic matter. Diagnosis can be challenging due to its slow progression and similarity to other skin conditions, but with appropriate treatment, the prognosis can be favorable.
Causes & Symptoms
Clinical Causes: Inoculation of fungi such as *Fonsecaea* and *Phialophora* species into the skin through cuts, abrasions, or puncture wounds. Prolonged exposure to soil, plant material, or decaying vegetation in tropical or subtropical climates. Injury or trauma during agricultural or outdoor activities that introduces pathogenic fungi. Rarely, person-to-person transmission, but mostly acquired from environmental sources.
Key Symptoms: Appearance of wart-like or verrucous lesions on the skin, often with a dark or pigmented surface. Lesions typically develop slowly, enlarging over months or years. Areas affected are commonly on the limbs, particularly the legs and arms. Chronic ulcers or plaques that can become crusted or scarred. Possible itching, discomfort, or mild pain in affected areas. In some cases, secondary bacterial infections may occur, complicating the condition.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chromomycosis involves a combination of clinical examination and laboratory tests. A healthcare provider will consider the patient's history of exposure and lesion appearance. Confirmatory diagnosis often includes direct microscopic examination of skin scrapings or biopsies, where characteristic pigmented fungal elements called 'sclerotic cells' or 'Medlar bodies' can be observed. Fungal culture and histopathological analysis help identify the specific causative organism. Imaging studies are rarely needed but may be used if deeper tissue involvement or complications are suspected.
Treatment Protocols: Treatment strategies focus on eliminating the fungal infection and managing skin lesions. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is B43.9 a billable ICD-10 code?
Yes, B43.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B43.9?
Clinical documentation must specify the nature of Chromomycosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference